Exonate
PrivateLast Round
Series A
Jan 3, 2019
Total Funding Raised
$11.79M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Exonate is a biopharmaceutical company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exonate Comparables
Compare Exonate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PanOpttica | 88% | |
| Retinset, S.L. | 82% | |
| Anida Pharma | 82% | |
Exonate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 3, 2019 | ||||
| Grant | Feb 6, 2017 | ||||
| Angel | Nov 30, 2016 | ||||
| Angel | Oct 5, 2015 | ||||
| Seed | Apr 3, 2014 |
Exonate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACF Investors | Angel, Series A |
| IP Group | Seed |
| o2h ventures | Angel, Series A |
| University of Bristol Enterprise Fund | Angel, Series A |
| Uniseed | Angel, Series A |
| Parkwalk Advisors | Angel, Series A |
| Wren Capital | Angel, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 58% MoM.
- Feb 6, 2017
Secured $6.1M from Wellcome Trust.
Exonate Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exonate's valuation, stock price, and market status.